Electrolytes Flashcards
Causes of proximal RTA?
- Primary
- Idiopathic/sporadic
- Familial:
- Recessive (proximal tubule Na/HCO3 co-transporter defect, carbonic anhydrase type 2 deficiency)
- Dominant, isolated HCO3 wasting
- Cystinosis
- Tyrosinemia
- Hereditary fructose intolerance
- Galactosemia
- Glycogen storage disease type I
- Wilsons
- Lowe syndrome
- Acquired
- Drugs: Ifosfamide, tenofovir/ARTs, carbonic anhydrase inhibitors, aminoglycosides, cisplatin/oxaliplatin
- Monoclonal: MM/light chain, amyloidosis
- Heavy metals: lead, mercury, copper, cadmium
- Vitamin D deficiency
- Renal transplant
- Paroxysmal nocturnal hemoglobinuria
- Sjogren’s (more commonly distal RTA)
DDx for Fanconi’s syndrome - congenital and acquired
- Inherited:
- Cystinosis
- Wilson’s disease
- Acquired:
- Paraproteinemia – light chain nephropathy (proximal tubular uptake of light chains)
- Drugs – carbonic anhydrase inhibitors (acetazolamide, topiramate), tenofovir, aminoglycosides, ifosfamide)
- Heavy metal toxicity – lead, mercury, copper
- Post-renal transplant
- PNH
- Sjogren’s (more commonly distal RTA)

Causes of distal RTA?
- Primary
- Idiopathic/sporadic
- Familial
- Autosomal dominant
- Autosomal recessive
- Secondary
- Autoimune: Sjogren’s, SLE, RA, AIH/PBC
- Drugs: Ibuprofen, lithium, amphotericin B, ifosfamide
- Hypercalciuric conditions: hyperPTH, VitD intoxication, sarcoidosis, idiopathic hypercalciuria
- Other: medullary sponge kidney, obstructive uropathy, RTx rejection, Wilson’s disease
Causes of type 4 RTA
- Decreased aldosterone production
- Decreased renin
- CNI
- NSAIDs
- DM
- HIV
- Decreased aldosterone
- ACE/ARBs
- Heparin
- Addison’s
- Gordon’s syndrome (pseudohypoaldo type 2)
- Decreased renin
- Increased aldosterone resistance
- Aldo blockade
- MRA
- ENaC blockade
- Amiloride
- Triampterene
- Septra
- Pseudohypoaldosteronism type 1
- Aldo blockade
What is the equation for total free water deficit?
Free water deficit = TBW x (Na-140)/140
TBW =0.6 male or 0.5 female x weight (kg)
DDx for nephrogenic DI?
- Congenital: Inherited mutations in genes for AVP V2-receptors or AQP2.
- Acquired
- Drugs: Lithium (most common), demeclocyline, amphotericin, foscarnet
- Hypokalemia, hypercalcemia
- Tubulointerstitial disease (problem with urine concentrating): CKD, post-ATN, post-obstruction, amyloid, Sjogren’s, medullary cystic
- Sickle cell disease (sickled RBCs occlude vasa recta, cause papillary damage -> medullary infarcts)
- Pregnancy/gestational DI (placenta producing AVPase)
- Protein malnutrition+excessive water intake
4 Non-drug reasons for increased ADH
1) Increase in serum osmolality
2) Volume contraction
3) Effective circulating volume depletion (despite low plasma osmolality): vomiting, cirrhosis, heart failure
4) Non-osmotic/Non-volume related: Nausea, Pain, Pregnancy
SIADH diagnostic criteria
- Clinical euvolemic
- Serum Osm low <275 mOsm/kg H20
- Urine Na high (usually >40)
- Urine Osm >300
- Normal TSH and AM cortisol
- Serum ADH high or in “normal” range (but inappropriately normal, given hypo-osmolar state)
8 drugs causing hyperkalemia and mechanism for each
- ACE/ARB - Blocks aldosterone production, decreased GFR
- Spironolactone – Blocks aldosterone receptor
- Septra – block EnAC
- Heparin – Impaired aldosterone metabolism
- NSAIDS – impaired release of renin, decreased GFR
- Beta-Blockers – impaired release of renin
- CNI – increased NCC at DCT, decreased delivery of sodium, impared na-k a principal cell, inhibit ROMK
Mechanisms of drug-induced hyperkalemia
1) Block ENac sodium channel in DCT Amiloride, triamterene, trimethoprim, pentamidine
2) Block Na-K ATPase in DCT Calcineurin inhibitors
3) Block aldosterone production ACEi, ARB, NSAIDS, Heparin
4) Block aldosterone receptors Spironolactone, eplerenone
5) Block K disposal Beta-blockers, digoxin, somatostatin
Function of principal cells and intercalated cells
- Principal cells responsible for Na reabsorption and K excretion (ENAC channels and ROMK). Main Na+ reabsorbing cells and the site of action of aldosterone, K+-sparing diuretics, and spironolactone.
- Type A and B intercalated cells make up the second cell type in the collecting duct epithelium.
- Type A intercalated cells mediate ACID secretion and bicarbonate reabsorption.
- Type B intercalated cells mediate BICARB secretion and acid reabsorption.
Tenofovir-induced RTA biopsy findings?
- Biopsy shows proximal tubule eosinophilic inclusions with giant mitochondria, +/- HIV-findings
How does hypercalcemia affect the kidney?
- Vasoconstriction of afferent arteriole and decreased GFR
- Activation of Ca sensing receptors in loop of Henle -> inhibit NKCC channel -> volume contraction
- Inhibit ADH-dependent water reabsorption in collecting duct -> nephrogenic DI
- Distal RTA
- Nephrocalcinosis
- Nephrolithiasis
Pathophysiology of alkalosis in milk alkali syndrome for 1) initiation and 2) maintenance of alkalosois
- Initiation
- Alkali load from calcium carbonate
- Hypercalcemia-induced decreased GFR
- Maintenance
- Hypercalcemia-induced volume depletion/diuresis (CaSR LOH NKCC and AQP2) -> secondary hyperaldo
- Vomiting
- loss of H+
- volume contraction -> secondary hyperaldo
Factors influencing proximal bicarb reabsorption
- Intracellular acidosis -> more available for luminal Na/H exchanger -> basolateral Na/HCO3 cotransporter
- Metabolic acidosis
- Hypokalemia
- Decreased extracellular volume -> increased Na/HCO3 cotransporter reabsorption
- Hormones:
- Angiotensin II -> increase Na/HCO3 reabsorption
- Glucocorticosteroids -> same
- Endothelin-1 -> same
Calculation for FENa
FENa = [Urine Na x Serum Cr] / [Serum Na x Urine Cr] x 100%
Limitations of FENa
- High FENa:
- CKD - maximal tubular reabsorption of Na in response to volume depletion is impaired to begin with
- Diuretic use - can use FEUrea (<35%) instead (proximal absorption urea vs. loop/thiazide affect more distal), but has its own limitations too
- Non-reabsorbable anion - will impair proximal Na reabsorption (maintain urinary electroneutrality)
- Low FENa
- Neurohormonal activation leading to sodium retention/low FENa despite ATN eg. severe HF, liver failure, extensive burns
- Acute GN - low urine Na b/c tubular reabsorptive ability is intact and there is an acute decrease in glomerular surface area available for filtration ie. normal tubular function responding to acute decrease in GFR
- Non-oliguric interstitial nephritis - normal tubular function responding to acute decrease in GFR
- Also: Variability in timing of measurement
When is FEUrea not accurate?
When proximal salt and water reabsorption impaired:
- acetazolamide
- glycosuria eg. DM
- osmotic diuresis eg. mannitol
- cerebral salt wasting
- increased urea excretion (high protein intake or catabolism)
Studies on FEUrea have not included patients with AIN, GN, obstruction, contrast
Causes of low FENa that is NOT pre-renal?
- Early ATN
- Acute GN
- Acute nonoliguric AIN
- Radiocontrast dye (ionic)
- Rhabdo
- TTP
Renal causes of hypomagnesemia
- Think about sites of loss - prox tubule, TAL, and DCT
- DDx:
- Proximal tubule
- Fanconi’s
- TAL
- Loop diuretic
- (Barters - not really)
- Hypercalcemia (stimulate basolateral CaSR in TAL)
- Hypokalemia
- DCT
- Thiazide
- Gitelmans
- Other:
- Gentamicin
- Chemo (cisplatin)
- CNIs
- Proximal tubule
What is Gordon’s syndrome?
Pseudohypoaldosteronism type 2 (PHA2): Genetic mutation involving the NaCl transporter in DCT, causes hyperkalemia, hypertension, NAGMA, normal renal function, and low or low-normal plasma renin activity and aldosterone concentrations due to volume expansion.
Presents in childhood
Stimuli for ADH release?
- Osmotic stimuli:
- Hypertonic saline, mannitol
- Non-osmotic stimuli:
- Decreased effective circulating volume
- Nausea
- Pain
- Pregnancy
- Fructose
How many ADH receptors and where are they located?
- 3 receptors:
- V1a - vascular and hepatioc
- V1b - anterior pituiatry and pancreatic islet
- V2 - renal
Where are the AQP1, AQP2, AQP3, AQP4 channels located
AQP1- apical and basolateral proximal tubule and descending loop of Henle (not regulated by ADH)
AQP2 - apical collecting duct (regulated by ADH)
AQP3 - basolateral collecting duct(all)
AQP4 - basolateral collecting duct (in the inner medulla)
Hormonal and physiologic factors that affect HCO3 reabsorption
- Hormonal
- Aldosterone
- Angiotensin II
- Cortisol
- Endothelin-1
- Physiologic
- Hypovolemia
- Hypokalemia
- Acidosis
Electrolyte abnormalities with aminoglycoside nephrotoxicity
- Proximal dysfunction/Fanconi-like
- Glycosuria, phosphaturia, uricosuria, aminoaciduria
- Decreased proximal delivery
- Hypomagnesemia
- Hypokalemia
- Hypocalcemia
Pathophysiology and manifestations of aminoglycoside nephrotoxicity
- Most of aminoglycoside gets renally excreted but 5-10% proximal tubular transport (it’s a cation)
- Onset of AKI at 5-7 days
-
Distal tubular dysfunction
- initially concentrating defect manifested as polyuria (decreased sensitivity to ADH)
- Non-oliguric AKI with FeNa >1%
- Reversible progressive loss of kidney function, lag until recovery after drug discontinued due to accumulation in renal cortical tissue. Complete recovery within several weeks.
- Bland urinalysis
- Fanconi-like syndrome: Urinary phosphate and magnesium wasting (magnesium depletion leads to hypokalemia and hypocalcemia)
Mechanism of action and site of action of Lasix and amiloride
- Lasix – thick ascending Loop of Henle, inhibits NKCC channel
- Amiloride- Principal cell in collecting tubule, inhibits ENac at apical membrane (inhibit Na reabsorption)
% filtered Na reabsorbed in the proximal tubule vs. TAL vs. DT, CT
% filtered NaCl reabsorbed:
- Proximal tubule: 67% (Na-H exchange, Na cotransport with AAs/organic solutes, Na/H-Cl/anion exchange, paracellular reabsorption)
- Thick ascending limb (Loop of Henle): 25% (Na-K-2Cl symport)
- Distal tubule: 5% (NaCl symport)
- Late distal tubule/cortical collecting duct: 3% (Na channels)
Potassium handling in the nephron
- Proximal tubule: 67% (passive reabsorption only)
- Loop of henle (TAL): 20% (passive reabsorption only)
- Reabsorb most K in proximal tubule, regulate with distal secretion
- Distal convoluted tubule (late):
- 3% reabsorbed if K-deplete (intercalated cells)… H/K ATPase (hydrogen out, k in)
- 10-50% secreted if K-normal/high (principal cells) – predominant mechanism
- Cortical collecting duct:
- 9% reabsorbed if K-deplete
- 5-30% secreted if K-normal/high
Metabolic alkalosis DDx
- Intracellular shift - hypokalemia
- GI - vomiting (lose H), laxative abuse, villous adenoma, congenital chloride diarrhea
- Renal
- Excess mineralcorticoid (HTN)
- Chloride-wasting diuretic, loop or thiazide (low/normal BP)
- Barters, Gitelmans (low/normal BP)
- Pendred syndrome (autorecess disorder/decreased pendrin activity ie. decreased HCO3/Cl exchanger in B-intercalated)
- Posthypercapnic alkalosis
- Hypercalcemia or milk-alkali
Treatment for Bartter’s or Gitelman’s
- Liberal sodium, potassium, magneisum intake and supplementation
- NSAIDs to decrease GFR, and also inhibit prostaglandins, which are increased in Bartter’s
- Decrease distal activity of Na/K exchanger (decrease K loss)
- Amiloride
- MRA
- ACE/ARBs
- Kidney transplantation (reverses without recurrence)
Diagnosis in a 18 year old woman with HTN, hyperkalemia, low renin and low aldo?
Gordon’s syndrome
3 drugs that inhibit Na channel in the CCD
- Amiloride
- Triamterene
- Trimethoprim
Patient with metabolic alkalosis and hypokalemia from vomiting, are each of the following high or low (acute):
pCO2
Urine Na
Urine K
Urine Cl
Urine HCO3
urine pH
pCO2 high (compensation)
Urine Na high (secrete bicarb)
Urine K high (proximal loss to get rid of bicarb, mild contribution from increased aldo activity to reabsorb Na at the cost of K secretion)
Urine Cl low (increased Na reabsorption)
Urine HCO3 high
Urine pH high (bicarbaturia)
Patient with metabolic alkalosis and hypokalemia from vomiting, are each of the following high or low (CHRONIC):
pCO2
Urine Na
Urine K
Urine Cl
Urine HCO3
Urine NH4
urine pH
Everything same as acute except: (bicarb reabsorption does not exceed threshold anymore)
Urine Na low
Urine K low
Urine HCO3 low
Urine pH low
(not sure about NH4)
Causes of hypophosphatemia
- Redistribution
- Insulin/refeeding syndrome
- Acute respiratory alkalosis
- Hungry bone syndrome
- Decreased GI absorption
- Malnutrition
- Chronic diarrhea
- Vitamin D deficiency
- Antacids - aluminum or magnesium-based
- Renal wasting
- Primary or secondary hyperparathyroidism
- Fanconi syndrome
- Acute volume repletion (proximal sodium wasting)
- Osmotic diuresis (glucosuria)
Causes of hypophosphatemia early post-transplant?
- Persistent hyperparathyroidism
- High FGF-23
- Massive initial diuresis
- Osmotic diuresis from glucosuria
- Impaired phosphate reabsorption from ischemic injury
- Steroids (inhibit proximal reabsorption)
- Continued phosphate binders
- Malnutrition
4 causes of hyperkalemia in HIV patient with PJP on multiple meds
Hyporeninic hypoaldosteronism /type 4 RTA due to HIV
Inhibition of ENaC/type 4 RTA due to Septra or pentamidine
Decreased GFR due to HIVICK
Adrenal insufficiency
Pt w/ hypoK, low aldo, low renin, HTN. Dx?
Liddle’s
Apparent mineralocorticoid excess
Licorice ingeestion
Cushing’s syndrome exogenous steroids
CAH (11 B-hydroxylase deficiency)
Factors that control renin release
- Decreased perfusion pressure in the afferent arteriole
- Activation of sympathetic nerve fibres via cardiac and arterial baroreceptors
- Decreased distal NaCl delivery to macula densa (eg. decreased GFR)

Advantages and disadvantages of bicarb in treating cardiogenic shock
- Advantages (theoretical)
- Improve cardiac contractility
- Prevents tissue hypoperfusion from severe acidosis
- Disadvantages
- Post recovery metabolic alkalosis
- Hypernatremia/sodium load
- Volume overload
- Paradoxical decrease in intracellular pH (transiently increased bicarb, because converted to CO2, which moves into cells
Why does post-hypercapnic metabolic alkalosis occur?
Chronic resp acidosis -> increased renal H+ excretion/NH4Cl loss, increased renal bicarb reabsorption -> normalize pH
Rapid lowering of pCO3 -> HCO3 remains elevated, especially if:
1) volume contracted
2) low eGFR
3) Cl- deficient
Treatment: volume replae with NaCl, replace K if low, acetazolamide
Risk factors for osmotic demyelination syndrome
- Na <105 (or <120)
- Longer duration of hyponatremia (>2-3 days or chronic)
- Rapid rate of correction
- Alcoholic
- Malnourished
- Liver disease
- Hypokalemia
Risk factors for cerebral edema
- Acute water intoxication in marathon runners, psychogenic polydipsia, ecstasy (ADH+intake)
- Postoperative fluid administration to those with elevated ADH (from pain, nausea, drugs, hypotension)
- Children
How could you have a high FENa in DKA despite hypovolemia?
Osmotic diuresis, not correcting for glucose for serum Na
% magnesium handling
- PT: 25%, paracellular/passive
- TAL: 65%, paracellular (claudin-16 and claudin-19)
- DCT: 5% transcellular (TRPM6 apical, Na/Mg exchanger basolateral)
- CT: <2%
Difference between Bartters and Gitelmans
Bartters - concentrating defect present, hypercalciuria, usually normal Mg(or midlly low) and normal Ca, increased prostaglandins
Gitelman’s - hypoMg more prominent, hypercalcemia/hypocalciuria ie. impaired Ca excretion (normally thiazides increase proximal Ca reabsorption)
Similarities: both volume deplete, hypokalemic, metabolic alkalosis, normal UCl (because decreased Cl reabsorption with NKCC or NaCl inhibition)
DDx for HTN and hypokalemia
- Renin (indirectly activates angiotensin II, which causes Na and water reabsorption) Increased PAC, Increased PRA
- Renal artery stenosis
- Renin-secreting tumor
- Adrenal: mineralocorticoid (releases aldosterone, which causes Na and water reabsorption) Increased PAC, Decreased PRA
- Primary hyperaldosteronism (Conns=adrenal adenoma, bilateral adrenal hyperplasia, adrenal carcinoma, GRA=glucocorticoid remediable aldosteronism)
- Adrenal: corticosteroid (stimulates mineralocorticoid activity) Decreased PAC, Decreased PRA
- Cushing’s syndrome
- Exogenous steroids
- Congenital adrenal hyperplasia
- Receptor (stimulates mineralocorticoid receptor) Decreased PAC, Decreased PRA
- 3) Licorice
- AMA=Apparent mineralocorticoid excess
- ENaC (upregulation of Na channel in DCT/CD) Decreased PAC, Decreased PRA
- Liddle’s syndrome
3 electrolyte/metabolic changes with hyperglycemia
- Hyperosmolality
- Hyponatremia
- Hyperkalemia (in the setting of some insulin deficiency)
% phosphate handling in nephron
- Proximal:70-80% (Na/phos cotransporters)
- Distal: 20-30% (unknown)